Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
disease | 0.200 | None | 0.962 | 26 | 1 | 1990 | 2020 | ||||||||
|
steroid 5 alpha-reductase 2 | 0.564 | 0.615 |
|
disease | 0.100 | None | 0.882 | 17 | 8 | 2004 | 2019 | |||||||||
|
mastermind like domain containing 1 | 0.650 | 0.500 | 0.63 |
|
disease | 0.400 | None | 1.000 | 14 | 2 | 2006 | 2018 | ||||||||
|
nuclear receptor subfamily 5 group A member 1 | 0.479 | 0.731 | 0.99 |
|
disease | 0.200 | None | 0.917 | 12 | 5 | 2009 | 2017 | ||||||||
|
diacylglycerol kinase kappa | 0.780 | 0.385 |
|
disease | 0.470 | None | 1.000 | 9 | 8 | 2011 | 2019 | |||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 0.080 | None | 0.875 | 8 | 1 | 2006 | 2020 | ||||||||
|
sex determining region Y | 0.456 | 0.808 |
|
disease | 0.170 | None | 0.857 | 7 | 0 | 1995 | 2019 | |||||||||
|
activating transcription factor 3 | 0.494 | 0.885 | 8.9E-02 |
|
disease | 0.370 | None | 1.000 | 7 | 1 | 2005 | 2018 | ||||||||
|
estrogen receptor 2 | 0.400 | 0.923 | 4.5E-08 |
|
disease | 0.060 | None | 1.000 | 6 | 3 | 2006 | 2016 | ||||||||
|
midline 1 | 0.621 | 0.654 | 0.98 |
|
disease | 0.140 | None | 1.000 | 4 | 0 | 2003 | 2013 | ||||||||
|
cytochrome P450 family 17 subfamily A member 1 | 0.462 | 0.769 | 2.6E-04 |
|
disease | 0.140 | None | 1.000 | 4 | 1 | 2011 | 2019 | ||||||||
|
fibroblast growth factor 10 | 0.530 | 0.692 | 0.94 |
|
disease | 0.230 | None | 0.750 | 4 | 0 | 2004 | 2019 | ||||||||
|
WT1 transcription factor | 0.422 | 0.808 | 1.00 |
|
disease | 0.140 | None | 1.000 | 4 | 3 | 1999 | 2018 | ||||||||
|
cytochrome P450 family 19 subfamily A member 1 | 0.410 | 0.885 | 1.7E-05 |
|
disease | 0.040 | None | 1.000 | 4 | 1 | 2012 | 2020 | ||||||||
|
fibroblast growth factor receptor 2 | 0.380 | 0.808 | 1.00 |
|
disease | 0.220 | None | 1.000 | 3 | 3 | 2007 | 2019 | ||||||||
|
bone morphogenetic protein 7 | 0.498 | 0.769 | 0.13 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2003 | 2013 | ||||||||
|
hydroxysteroid 17-beta dehydrogenase 3 | 0.641 | 0.346 | 8.5E-07 |
|
disease | 0.030 | None | 1.000 | 3 | 2 | 2010 | 2018 | ||||||||
|
homeobox A13 | 0.552 | 0.654 | 0.96 |
|
disease | 0.320 | None | 1.000 | 3 | 0 | 2003 | 2016 | ||||||||
|
cytochrome P450 family 1 subfamily A member 1 | 0.436 | 0.846 | 1.1E-17 |
|
disease | 0.030 | None | 1.000 | 3 | 1 | 2005 | 2019 | ||||||||
|
fibroblast growth factor 8 | 0.507 | 0.769 | 0.68 |
|
disease | 0.220 | None | 0.667 | 3 | 0 | 2007 | 2019 | ||||||||
|
SRY-box transcription factor 9 | 0.419 | 0.846 | 1.00 |
|
disease | 0.120 | None | 1.000 | 2 | 0 | 2017 | 2019 | ||||||||
|
steroid 5 alpha-reductase 1 | 0.631 | 0.538 | 1.2E-05 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2004 | 2013 | ||||||||
|
3-hydroxyanthranilate 3,4-dioxygenase | 0.644 | 0.538 | 1.1E-08 |
|
disease | 0.110 | None | 1.000 | 2 | 1 | 2014 | 2019 | ||||||||
|
matrix metallopeptidase 11 | 0.542 | 0.692 | 2.4E-05 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2012 | 2012 | ||||||||
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 | 0.582 | 0.500 | 7.2E-08 |
|
disease | 0.420 | None | 1.000 | 2 | 0 | 2004 | 2015 |